Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Gabutti, Luca ^a   Salvadé, Igor ^a   Lucchini, Barbara ^a   Soldini, Davide ^a   Burnier, Michel ^b  

^a Ospedale la Carit   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

dialysis fluids; haemodialysis; Haemodynamics; hypotension; potassium

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMODIALYSIS FLUID; POTASSIUM;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; COMORBIDITY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSATE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HYPOTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; ISCHEMIC CARDIOMYOPATHY; KIDNEY DISEASE; MALE; NEPHROANGIOSCLEROSIS; POTASSIUM BLOOD LEVEL; PROLIFERATIVE GLOMERULONEPHRITIS; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; THROMBOTIC THROMBOCYTOPENIC PURPURA; ULTRAFILTRATION; VASCULAR RESISTANCE; BLOOD; BLOOD PRESSURE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; METHODOLOGY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY;

BLOOD PRESSURE; CROSS-OVER STUDIES; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; HYPOTENSION; MALE; POTASSIUM; RENAL DIALYSIS; STROKE VOLUME; VASCULAR RESISTANCE;

EID: 79953650734     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-14     Document Type: Article

References (28)

1. Hypokalaemia and hyperkalaemia. A Rastegar M Soleimani, Postgrad Med J 2001 77 759 764 PMID: 11723313 10.1136/pmj.77.914.759 11723313 (Pubitemid 33116510)
2. Extrarenal potassium homeostasis. MJ Bia RA DeFrontzo, Am J Physiol 1981 240 257 268 PMID: 6111930
3. Impaired extrarenal disposal of an acute oral potassium load in patients with end-stage renal disease on chronic hemodialysis. J Fernandez JR Oster GO Perez, Miner Electrolyte Metab 1986 12 125 129 PMID: 3960016 3960016 (Pubitemid 16129531)
4. Blunted kaliuresis after an acute potassium load in patients with chronic renal failure. GO Perez R Pelleya JR Oster DC Kem CA Vaamonde, Kidney Int 1983 24 656 662 PMID: 6663988 10.1038/ki.1983.208 6663988 (Pubitemid 14208763)
5. Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5). CG Musso, Int Urol Nephrol 2004 36 469 472 PMID: 15783126 10.1007/s11255-004-6194-y 15783126
6. Acute decreases in serum potassium augment blood pressure. GM Dolson KJ Ellis MV Bernardo R Prakash HJ Adrogué Am J Kidney Dis 1995 26 321 326 PMID: 7645536 10.1016/0272-6386(95)90652-5 7645536
7. Optimal composition of the dialysate, with emphasis on its influence on blood pressure. F Locatelli A Covic C Chazot K Leunissen J Lũo M Yaqoob, Nephrol Dial Transplant 2004 19 785 796 PMID: 15031331 10.1093/ndt/gfh102 15031331 (Pubitemid 38455647)
8. Normotensive salt sensitivity: effects of race and dietary potassium. RC Morris Jr A Sebastian A Forman M Tanaka O Schmidlin, Hypertension 1999 33 18 23 PMID: 9931076 9931076 (Pubitemid 29061836)
9. Findings of the International Cooperative INTERSALT Study. J Stamler G Rose P Elliott A Dyer M Marmot H Kesteloot R Stamler, Hypertension 1991 17 9 15 PMID: 1987018 1987018
10. Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. PK Whelton J He JA Cutler, et al. JAMA 1997 277 1624 1632 PMID: 9168293 10.1001/jama.277.20.1624 9168293 (Pubitemid 27231195)
11. + channels in vascular smooth muscle during hypertension. GC Amberg AD Bonev CF Rossow MT Nelson LF Santana, J Clin Invest 2003 112 717 724 PMID: 12952920 12952920 (Pubitemid 38057712)
12. Role of potassium in regulating blood flow and blood pressure. FJ Haddy PM Vanhoutte M Feletou, Am J Physiol Regul Integr Comp Physiol 2006 290 546 552 PMID: 16467502 10.1152/ajpregu.00491.2005
13. Cardiovascular function in dogs with acute hypokalemia. K Prasad R Koob, Angiology 1978 29 589 600 PMID: 686495 10.1177/000331977802900803 686495 (Pubitemid 9161611)
14. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. F Rodrigo J Shideman R McHugh T Buselmeier C Kjellstrand, Ann Intern Med 1977 86 554 561 PMID: 851303 851303 (Pubitemid 8091105)
15. Intradialytic hypotension - new concepts on an old problem. FM Van der Sande JP Kooman KM Leunissen, Nephrol Dial Transplant 2000 15 1746 1748 PMID: 11071958 10.1093/ndt/15.11.1746 11071958
16. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. L Gabutti G Bianchi D Soldini C Marone M Burnier, Nephrol Dial Transplant 2009 24 973 981 PMID: 18842671 10.1093/ndt/gfn541 18842671
17. Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis. L Gabutti N Ferrari G Giudici G Mombelli C Marone, Nephrol Dial Transplant 2003 18 2369 2376 PMID: 14551368 10.1093/ndt/gfg383 14551368 (Pubitemid 37336827)
18. Dialysis induced hypotension - a serious clinical problem in renal replacement therapy. W Suowicz A Radziszewski, Med Pregl 2007 60 14 20 PMID: 18928150 18928150
19. Preventing haemodynamic instability in patients at risk for intra-dialytic hypotension. KM Leunissen JP Kooman W van Kuijk F van der Sande AJ Luik JP van Hooff, Nephrol Dial Transplant 1996 11 11 15 PMID: 8803987 8803987 (Pubitemid 26182536)
20. Dialysate magnesium level and bood pressure. J Kyriazis K Kalogeropoulou L Bilirakis N Smirnioudis V Pikounis D Stamatiadis E Liolia, Kidney Int 2004 66 1221 1231 PMID:15327421 10.1111/j.1523-1755.2004.00875.x 15327421 (Pubitemid 39121032)
21. A systematic review of the clinical effects of reducing dialysate fluid temperature. NM Selby CW McIntyre, Nephrol Dial Transplant 2006 21 1883 1898 PMID: 16601075 10.1093/ndt/gfl126 16601075 (Pubitemid 43985717)
22. Vascular reactivity during combined ultrafiltration-haemodialysis: influence of dialysate sodium. WH Van Kuijk JJ Wirtz W Grave F de Heer PP Menheere JP van Hooff KM Leunissen, Nephrol Dial Transplant 1996 11 323 328 PMID: 8671787 8671787 (Pubitemid 26063079)
23. Optimization of dialysate sodium in sodium profiling haemodialysis. MJ Kim J Song G Kim H Lim S Lee, Nephrology (Carlton) 2003 8 16 22 PMID: 15012686 10.1046/j.1440-1797.8.s.2.x 15012686
24. Sodium and body fluid homeostasis in profiling hemodialysis treatment. I Stefanidis S Stiller V Ikonomov H Mann, Int J Artif Organs 2002 25 421 428 PMID: 12074340 12074340
25. A critical review of sodium profiling for hemodialysis. S Stiller E Bonnie-Schorn A Grassmann I Uhlenbusch-Körwer H Mann, Semin Dial 2001 14 337 347 PMID: 11679103 10.1046/j.1525-139X.2001.00086.x 11679103 (Pubitemid 33720874)
26. Acute and chronic hypokalemia sensitize the isolated heart to hypoxic injury. JI shapiro A Banerjee OK Reiss N Elkins, Am J Physiol 1998 274 1598 1604 PMID:9612369
27. Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. GA Knoll A Sahgal RC Nair J Graham C Van Walraven KD Burns, Am J Med 2002 112 110 114 PMID:11835948 10.1016/S0002-9343(01)01068-3 11835948 (Pubitemid 34142541)
28. Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis. R Furuya H Kumagai T Sakao Y Maruyama A Hishida, Nephron 2002 92 576 581 PMID:12372940 10.1159/000064116 12372940